FDA Looks into Third-Party Service, Repair of Devices

摘要

Diving into what can be a contentious debate, the Food and Drug Administration (FDA) is gathering information from original equipment manufacturers (OEMs), third-party companies, and the healthcare community about the service repair, refurbishment, rebuilding, remarketing, and remanufacturing of medical devices ahead of a public meeting that will be held later this year.